Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Short-Term Debt issuances (2023)

Immucell's Short-Term Debt issuances history spans 1 years, with the latest figure at $1.0 million for Q3 2023.

  • For Q3 2023, Short-Term Debt issuances changed N/A year-over-year to $1.0 million; the TTM value through Dec 2023 reached $2.0 million, changed N/A, while the annual FY2023 figure was $2.0 million, N/A changed from the prior year.
  • Short-Term Debt issuances reached $1.0 million in Q3 2023 per ICCC's latest filing, roughly flat from $1.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $1.0 million in Q1 2023 to a low of $1.0 million in Q1 2023.